Data from: Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland

Päivi Ruokoniemi, Reijo Sund, Martti Arffman, Arja Helin-Salmivaara, Risto Huupponen, Ilmo Keskimaki, Tuulikki Vehko & Maarit Korhonen
Objective: To assess the representativeness of the Heart Protection Study (HPS) and the Collaborative Atorvastatin Diabetes Study (CARDS) for incident statin users. Design: A population based analysis with linked register data. Setting: Finland. Population: 56 963 diabetic patients initiating statin use in 2005 to 2008. Main outcome measures: We determined the proportions of real-world patients who fulfilled the eligibility criteria for HPS and CARDS trials and assessed the cardiovascular disease (CVD) event rates, assumed to...
1 citation reported since publication in 2014.
426 views reported since publication in 2014.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?
132 downloads reported since publication in 2014.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?